Skip to main content
AMGN
NASDAQ Life Sciences

EVP Sells $20.7M in Amgen Stock Following Option Exercise

AI Analysis by WiseekReviewed by Editorial Team
Sentiment info
Negative
Importance info
7
Price
$386.5
Mkt Cap
$207.918B
52W Low
$261.43
52W High
$391.29
Market data snapshot near publication time

summarizeSummary

Amgen's EVP of Operations, Esteban Santos, sold $20.7 million worth of common stock after exercising options, reducing his direct holdings.


check_boxKey Events

  • Executive Sells Significant Stake

    Esteban Santos, Amgen's EVP of Operations, sold 54,792 shares of common stock for a total value of $20.7 million.

  • Option Exercise Preceded Sale

    The sale followed the exercise of options to acquire 54,792 shares for $9.27 million, indicating a net cash-out from the transaction.

  • Discretionary Sale Near 52-Week High

    The transaction was not executed under a 10b5-1 plan and occurred while Amgen's stock is trading near its 52-week high, suggesting the executive is locking in profits.


auto_awesomeAnalysis

This Form 4 filing indicates a significant sale of Amgen stock by Esteban Santos, EVP of Operations. While a portion of the $20.7 million sale was likely to cover the exercise price of options and associated taxes, the transaction represents a substantial cash-out by a key executive. The sale occurred as Amgen's stock trades near its 52-week high, suggesting the executive is realizing gains. This discretionary sale, not under a 10b5-1 plan, could be interpreted by investors as a slightly negative signal regarding insider sentiment, despite the routine nature of option exercises.

At the time of this filing, AMGN was trading at $386.50 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $207.9B. The 52-week trading range was $261.43 to $391.29. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.

descriptionView Main SEC Filing

show_chartPrice Chart

Share this article

Copied!

feed AMGN - Latest Insights

AMGN
Mar 28, 2026, 4:45 PM EDT
Source: Reuters
Importance Score:
9
AMGN
Mar 05, 2026, 3:03 PM EST
Source: Wiseek News
Importance Score:
7
AMGN
Mar 02, 2026, 7:20 PM EST
Filing Type: 4
Importance Score:
7
AMGN
Feb 19, 2026, 4:27 PM EST
Filing Type: 8-K
Importance Score:
8
AMGN
Feb 17, 2026, 5:14 PM EST
Filing Type: FWP
Importance Score:
8